In the example of Fig. 6, the pulse-modulated ML was triggered with 100 kHz pulse-frequency at 100 μs before onset of 440 nm AL. At 1 ms after onset of AL, a saturating 50-μs multi-color ST pulse was applied. The ST pulse closes PS II reaction centers transiently, so that the I 1-level of fluorescence yield can be determined by extrapolation to 1,050 μs. I 1 corresponds to the maximal fluorescence yield that can be reached in the presence of an oxidized PQ-pool (for apparent PQ-quenching see Samson et al. 1999; PI3K inhibitor drugs Schreiber 2004). Weak FR background light or short FR-preillumination

is routinely applied to assure a fully oxidized PQ-pool. This aspect is particularly important in the study of algae and cyanobacteria, where depending on conditions the PQ-pool becomes more or less reduced in the dark via NADPH-dehydrogenase activity, resulting CHIR 99021 in more or less transition into state 2. Furthermore, FR-preillumination minimizes the contribution of “inactive PS II” to the O–I 1 kinetics. Fig. 6 Initial increase of fluorescence yield (O–I 1 rise) in a dilute suspension of Chlorella (300 μg Chl/L) induced

by 440-nm AL with 2,131 μmol quanta/(m2 s) in presence of FR background light. Dashed yellow lines indicate F o-level (O), assessed during a 50-μs period preceding onset of AL at time zero, and the I 1-level that is determined with the help of a saturating single-turnover pulse (ST) triggered 1 ms after onset of AL (see Fig. 2 for the Fast {Selleck Anti-infection Compound Library|Selleck Antiinfection Compound Library|Selleck Anti-infection Compound Library|Selleck Antiinfection Compound Library|Selleckchem Anti-infection Compound Library|Selleckchem Antiinfection Compound Library|Selleckchem Anti-infection Compound Library|Selleckchem Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|buy Anti-infection Compound Library|Anti-infection Compound Library ic50|Anti-infection Compound Library price|Anti-infection Compound Library cost|Anti-infection Compound Library solubility dmso|Anti-infection Compound Library purchase|Anti-infection Compound Library manufacturer|Anti-infection Compound Library research buy|Anti-infection Compound Library order|Anti-infection Compound Library mouse|Anti-infection Compound Library chemical structure|Anti-infection Compound Library mw|Anti-infection Compound Library molecular weight|Anti-infection Compound Library datasheet|Anti-infection Compound Library supplier|Anti-infection Compound Library in vitro|Anti-infection Compound Library cell line|Anti-infection Compound Library concentration|Anti-infection Compound Library nmr|Anti-infection Compound Library in vivo|Anti-infection Compound Library clinical trial|Anti-infection Compound Library cell assay|Anti-infection Compound Library screening|Anti-infection Compound Library high throughput|buy Antiinfection Compound Library|Antiinfection Compound Library ic50|Antiinfection Compound Library price|Antiinfection Compound Library cost|Antiinfection Compound Library solubility dmso|Antiinfection Compound Library purchase|Antiinfection Compound Library manufacturer|Antiinfection Compound Library research buy|Antiinfection Compound Library order|Antiinfection Compound Library chemical structure|Antiinfection Compound Library datasheet|Antiinfection Compound Library supplier|Antiinfection Compound Library in vitro|Antiinfection Compound Library cell line|Antiinfection Compound Library concentration|Antiinfection Compound Library clinical trial|Antiinfection Compound Library cell assay|Antiinfection Compound Library screening|Antiinfection Compound Library high throughput|Anti-infection Compound high throughput screening| kinetics trigger pattern). The slope of the relaxation kinetics is extrapolated to the end of the 50-μs ST. The black line represents the O–I 1 fit curve based on a PS II model which incorporates energy transfer between PS II units and reoxidation

of the primary PS II acceptor QA (see text) At a first approximation, assuming that the AL-driven increase of fluorescence yield is linearly correlated with accumulation of Q A − , and that the initial rise is negligibly slowed down by Q A − reoxidation, the kinetics can be described by a first order reaction, of which the time constant Tau = 1/k(II) corresponds to the time for reaching a QA-reduction level of 100(1 − 1/e) = 63.2 %. When this approximation is applied to the O–I 1 rise HA1077 of Fig. 6, Tau = 0.379 ms is estimated. A thorough analysis of the O–I 1 rise kinetics, however, has to take into account both Q A − reoxidation and nonlinearity between ∆F and the fraction of reduced Q A. This can be achieved by a fitting routine we have specially developed for this purpose (see “Materials and methods”). For the O–I 1 rise displayed in Fig. 6, which was driven by 2,131 μmol quanta/(m2 s) of 440-nm AL, the following values were estimated by the O–I 1 fit routine: Tau = 0.173 ms, k(II) = 1/Tau = 5.78 × 103/s, Tau(reox) = 0.340 ms, J = 2.01 (corresponding to p = 0.67), Sigma(II)440 = 4.51 nm2.